TRICAST Introduces Automated Solution Designed to Improve Poor CMS Five-Star Quality Ratings for Medicare Part D Plans


Save Story

Estimated read time: 2-3 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

[STK]

[IN] HEA INS PHA MTC FIN

[SU]

TO BUSINESS, AND HEALTH EDITORS:

TRICAST Introduces Automated Solution Designed to Improve Poor CMS

Five-Star Quality Ratings for Medicare Part D Plans

MILWAUKEE, March 28, 2014 /PRNewswire/ -- TRICAST, Inc., the nation's

leading pharmacy data analytics company, today revealed an automated

approach designed to help Medicare Part D Drug Plans improve the star

ratings given to them each year by the Centers for Medicare & Medicaid

Services (CMS).

"This is a real game-changer for anybody concerned with real-time

Medicare Part D plan oversight," says TRICAST President Greg Rucinski.

CMS created the Five-Star Quality Rating System in an effort to

educate consumers on quality and make quality data more transparent.

The rating gives an overall score on the drug plan's quality and

performance:

-- Drug plan customer service

-- Member complaints, problems getting services, and improvement in

the drug plan's performance

-- Member experience with the plan's drug services

-- Patient safety and accuracy of drug pricing

This information is gathered from several different sources. In some

cases it is based on member surveys. In other cases, it is based on

reviews of billing and other information that plans submit to

Medicare, or on results from Medicare's regular monitoring activities.

Starting in 2010, a bonus payment for plans receiving four or more

stars was introduced. These bonus payments are also available to plans

who are not rated, either because they were too new or had too few

enrollees. The bonus payments must be used for further improvements to

the plan's benefit offerings.

Rucinski continues: "Our combination of fraud, waste and abuse (FWA),

rejection and Part D surveillance systems can help our clients almost

immediately improve in 10 of the 15 stand-alone prescription drug plan

measures being used in 2014. Nobody else has this capability."

For more information on TRICAST's pending patent, please contact Greg

Rucinski at 414.302.9733 or Email.

About TRICAST

TRICAST, Inc. is a leading pharmacy data, analytics, and consulting

firm founded in 1997. TRICAST has leveraged more than 25 years of

technology and claims processing expertise, extensive client insight

and a team of industry experts to offer forward-thinking, full-scope

pharmacy benefit oversight solutions to its clients. TRICAST provides

audit services as the core of its business, and have assessed multiple

types of pharmacy programs. The company's broad experience across

payers of widely differentiated size and type, combined with focused

experience in pharmacy, enabling the delivery of comprehensive

assessments of pharmacy programs. Learn more by going to

www.tricast.com.

Read more news from TRICAST.

SOURCE TRICAST, Inc.

-0- 03/28/2014

/Web Site: http://www.tricast.com

CO: TRICAST, Inc.

ST: Wisconsin

IN: HEA INS PHA MTC FIN

PRN

-- PH92718 --

0000 03/28/2014 12:45:00 EDT http://www.prnewswire.com

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

The Associated Press
    KSL.com Beyond Series
    KSL.com Beyond Business

    KSL Weather Forecast

    KSL Weather Forecast
    Play button